Medios AG
MEDOF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.28B
Close$
$28.12
43.8% downside
Current Fair Value
43.8% downsideOvervalued by 43.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.28 Billion |
|---|---|
| Enterprise Value | $1.39 Billion |
| Earnings per Share | $0.61 |
| Beta | 1.26 |
| Outstanding Shares | 24,097,277 |
Return
| Return on Equity | 2.14% |
|---|---|
| Return on Assets | 1.22% |
| Return on Invested Capital | 5.89% |
Valuation & Multiples
| P/E Ratio | 23 |
|---|---|
| PEG | -52.58 |
| Price to Sales | 0.56 |
| Price to Book Ratio | 2.38 |
| Enterprise Value to Revenue | 0.64 |
| Enterprise Value to EBIT | 33.01 |
| Enterprise Value to Net Income | 124 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.38 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Medios AG
982 employees
CEO: Thomas Meier
Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. It operates through the following segments: Pharmaceutical Supply, Patient-Specific Therapies, and Services. The Pharmaceutical Supply segment focuse...